Recurrent conjunctival atypical fibroxanthoma in Pigmentosum Xeroderma

Jordá, 2012 Halkud, 2014, Xeroderma pigmentosum. Clinicopathological review of the multiple oculocutaneous malignacies and complications, Indian J Surg Oncol, 5, 120, 10.1007/s13193-014-0307-6 Moriwaki, 1999, Xeroderma pigmentosum bridging a gap between clinic and laboratory, Photodermatol Photoimmunol Photomed, 17, 47, 10.1034/j.1600-0781.2001.017002047.x Takebe, 1989, Melanoma and other skin cancers in xeroderma pigmentosum patients and mutations in their cells, J Invest Dermatol, 92, 236S, 10.1038/jid.1989.73 Goya, 1994, Oculo cutaneous manifestations of XP, Br J Ophthalmol, 78, 295 Shao, 2007, Atypical fibroxanthoma and squamous cell carcinoma of the conjuctiva in xeroderma pigmentosum, Pediatr Dex Pathol, 10, 149, 10.2350/06-06-0103.1 Gómez de la Fuente, 2005, Fibroxantoma atípico. Estudio clinicopatológico de 10 casos, Actas Dermosifiliogr, 96, 153, 10.1016/S0001-7310(05)73057-X Zalla, 1997, Mohs surgery vs wide excision for atypical fibroxanthoma: follow up, Dermatol Surg, 23, 1223, 10.1111/j.1524-4725.1997.tb00484.x Hasskarl, 2014, Everolimus, Recent Results Cancer Res, 201, 373, 10.1007/978-3-642-54490-3_23 TEVA Pharma B.V., 2008